| The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses G Antoine, F Scheiflinger, F Dorner, FG Falkner Virology 244 (2), 365-396, 1998 | 689 | 1998 |
| Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases F Fakhouri, JP Vernant, A Veyradier, M Wolf, G Kaplanski, R Binaut, ... Blood 106 (6), 1932-1937, 2005 | 365 | 2005 |
| ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases M Rieger, PM Mannucci, JAK Hovinga, A Herzog, G Gerstenbauer, ... Blood 106 (4), 1262-1267, 2005 | 348 | 2005 |
| Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic … S Ferrari, F Scheiflinger, M Rieger, G Mudde, M Wolf, P Coppo, JP Girma, ... Blood 109 (7), 2815-2822, 2007 | 302 | 2007 |
| von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke BQ Zhao, AK Chauhan, M Canault, IS Patten, JJ Yang, M Dockal, ... Blood, the Journal of the American Society of Hematology 114 (15), 3329-3334, 2009 | 293 | 2009 |
| Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13) B Plaimauer, K Zimmermann, D Völkel, G Antoine, R Kerschbaumer, ... Blood, The Journal of the American Society of Hematology 100 (10), 3626-3632, 2002 | 293 | 2002 |
| Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura F Scheiflinger, P Knöbl, B Trattner, B Plaimauer, G Mohr, M Dockal, ... Blood 102 (9), 3241-3243, 2003 | 286 | 2003 |
| Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura C Klaus, B Plaimauer, JD Studt, F Dorner, B Lämmle, PM Mannucci, ... Blood 103 (12), 4514-4519, 2004 | 259 | 2004 |
| ADAMTS13: a new link between thrombosis and inflammation AK Chauhan, J Kisucka, A Brill, MT Walsh, F Scheiflinger, DD Wagner The Journal of experimental medicine 205 (9), 2065-2074, 2008 | 257 | 2008 |
| Systemic antithrombotic effects of ADAMTS13 AK Chauhan, DG Motto, CB Lamb, W Bergmeier, M Dockal, B Plaimauer, ... Journal of Experimental Medicine 203 (3), 767-776, 2006 | 257 | 2006 |
| IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura S Ferrari, GC Mudde, M Rieger, A Veyradier, JAK Hovinga, F Scheiflinger Journal of Thrombosis and Haemostasis 7 (10), 1703-1710, 2009 | 208 | 2009 |
| Flow-induced elongation of von Willebrand factor precedes tension-dependent activation H Fu, Y Jiang, D Yang, F Scheiflinger, WP Wong, TA Springer Nature communications 8 (1), 324, 2017 | 199 | 2017 |
| Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients SFJ Whelan, CJ Hofbauer, FM Horling, P Allacher, MJ Wolfsegger, ... Blood, The Journal of the American Society of Hematology 121 (6), 1039-1048, 2013 | 197 | 2013 |
| Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin JD Studt, JAK Hovinga, G Antoine, M Hermann, M Rieger, F Scheiflinger, ... Blood 105 (2), 542-544, 2005 | 196 | 2005 |
| Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies B Plaimauer, JAK Hovinga, C Juno, MJ Wolfsegger, S Skalicky, ... journal of Thrombosis and Haemostasis 9 (5), 936-944, 2011 | 177 | 2011 |
| ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice F Denorme, F Langhauser, L Desender, A Vandenbulcke, H Rottensteiner, ... Blood, The Journal of the American Society of Hematology 127 (19), 2337-2345, 2016 | 163 | 2016 |
| Low ADAMTS13 activity is associated with an increased risk of ischemic stroke MAH Sonneveld, MPM de Maat, MLP Portegies, M Kavousi, A Hofman, ... Blood, The Journal of the American Society of Hematology 126 (25), 2739-2746, 2015 | 155 | 2015 |
| The mystery of antibodies against polyethylene glycol (PEG)-what do we know? C Lubich, P Allacher, M de la Rosa, A Bauer, T Prenninger, FM Horling, ... Pharmaceutical research 33, 2239-2249, 2016 | 154 | 2016 |
| Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice SF De Meyer, AS Savchenko, MS Haas, D Schatzberg, MC Carroll, ... Blood, The Journal of the American Society of Hematology 120 (26), 5217-5223, 2012 | 153 | 2012 |
| Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement M Noris, S Bucchioni, M Galbusera, R Donadelli, E Bresin, F Castelletti, ... Journal of the American Society of Nephrology 16 (5), 1177-1183, 2005 | 153 | 2005 |
Denisa D. WagnerHarvard Medical SchoolVerified email at childrens.harvard.edu
